A 17 (A-17)

1.	Berlin, Jordan D: 1 article (03/2008)
2.	Bauer, Todd M: 1 article (03/2008)
3.	Kawai, Ken-Ichi: 1 article (01/2008)
4.	Kawai, Ken-ichi: 1 article (01/2008)
5.	Takahashi, Yoshiki: 1 article (01/2008)
6.	Hayashi, Shunsuke: 1 article (01/2008)
7.	Itabashi, Takeshi: 1 article (01/2008)
8.	Kamei, Junzo: 1 article (01/2008)
9.	Kuchinskas, Sherri: 1 article (05/2007)
10.	Kornblum, C: 1 article (08/2006)

Related Diseases

1.	Stroke (Strokes) 06/03/2006 - "PATIENTS AND METHOD: Descriptive study of 480 patients with CS included in the Sagrat Cor Hospital of Barcelona Stroke Registry over a 17 year period" 01/01/2004 - "In addition, patients who had a TIA after the stroke had a 17% chance of having an early recurrent stroke, as compared with 4.4% among those that did not (p = 0.001)" 01/01/2002 - "Results show a 12% reduction in total mortality, a 17% reduction in vascular mortality, a 24% reduction in CHD events, a 27% reduction in all strokes and a 16% reduction in non-coronary revascularisations" 05/01/1979 - "Protamine 6 mg.kg-1 resulted in a 17% decrease in LV dP/dt max, a 26% decrease in cardiac output, a 50% decrease in LV stroke work and 25 and 30% decreases in systolic and diastolic pressures" 01/01/1983 - "A review of 30 studies of the literature (1,046 cases of acute stroke or transient ischemic attacks) shows a 17% global mortality, with 50% of good results" Get all the results and reference details, order at left...
2.	Syndrome 06/01/1985 - "Since Martland's first description of the syndrome in 1929, there has been only one randomly selected study of ex-boxers, that of Roberts, which showed a 17 per cent prevalence of this syndrome among boxers who fought between 1929 and 1955" 12/01/2006 - "We report a 17 year-old male and 23 year-old female with the syndrome" 08/01/2006 - "Global brain dysmyelination with above-average verbal skills in 18q- syndrome with a 17 Mb terminal deletion." 09/01/2005 - "We identified 19 causative mutations of CREBBP in a total of 45 patients representing three different diagnostic groups: (a) 17 mutations in 30 patients with unequivocal RSTS (detection rate 56.6%), (b) two mutations in eight patients with features suggestive of RSTS ("moderate or incomplete RSTS", detection rate 25%), and (c) no mutation in seven patients with undiagnosed syndromes and isolated features of RSTS" 01/01/2005 - "RESULTS: Mild ARMD caused a 17% decrement in the quality of life of the average patient, similar to that encountered with moderate cardiac angina or symptomatic human immunodeficiency virus syndrome" Get all the results and reference details, order at left...
3.	Myocardial Infarction 10/01/1998 - "CONCLUSIONS: Treatment by a cardiologist is associated with approximately a 17% reduction in hospital mortality in acute myocardial infarction patients" 02/01/1985 - "A 17 year old girl had a myocardial infarction" 07/01/1998 - "In group A, 17 (8%) patients and in group B, 11 (13%) patients suffered myocardial infarction (ns); 17 group A (8%) patients and 25 (29%) group B patients had bypass surgery (P < 0.0001), and 34 (15%) group A patients and 55 (63%) group B patients underwent repeat PTCA (P < 0.0001)" 09/01/1992 - "Coronary angioplasty in medically stabilized patients was complicated by an abrupt closure rate of 26%, and a 17% rate of myocardial infarction, death or need for emergency bypass grafting" 06/01/2003 - "These demonstrate a 17% reduction in total mortality, 25% reduction in cardiovascular mortality, 37% reduction in stroke and a 25% reduction in myocardial infarction for those patients under pharmacologic treatment." Get all the results and reference details, order at left...
4.	Smear Layer 04/01/1999 - "Before the root canal was filled the smear layer was removed from the root canal walls of both groups by rinsing the root canal with a 17% EDTA solution" 04/01/2007 - "This study compared the in vitro efficacy of Smear Clear (Sybron Endo, CA), a 17% ethylenediaminetetraacetic acid (EDTA) solution with surfactants, to 17% EDTA, with and without the use of ultrasonics, in removal of the smear layer" 07/01/2008 - "Twenty-four single rooted teeth were instrumented and divided into 2 groups according to the solutions for smear layer removal and the obturation materials employed: Group A - 17% EDTA-T and AH Plus with gutta-percha; Group B - primer and Epiphany with Resilon" Get all the results and reference details, order at left...
5.	Constipation 03/01/2004 - "CONCLUSION: In our series, the average time period from the initial onset of symptoms to the diagnosis was 6.9 days, with only one exception (a 17-year-old girl who had habitual constipation)" 07/01/2002 - "OBJECTIVES: Clinical studies in constipated adult patients have shown that a 17- or 34-g daily dose of polyethylene glycol (PEG) 3350 (MiraLax) is safe and effective for the treatment of constipation, with the best efficacy seen in wk 2 of treatment" Get all the results and reference details, order at left...
557 Diseases and 749 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Lipoproteins (Lipoprotein)
2.	Edetic Acid (EDTA)
3.	DNA (Deoxyribonucleic Acid)
4.	Aspirin (Acetylsalicylic Acid)
5.	Interferon-alpha (Interferon Alfa)
6.	Tablets
7.	Surface-Active Agents (Surfactants)
8.	Polyethylene Glycols (Polyethylene Glycol)
9.	Smear Clear
10.	Miralax
238 Drugs and Important Bio-Agents and 190 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)
2.	Lymph Node Excision (Lymph Node Dissection)
3.	Balloon Angioplasty (Angioplasty, Transluminal)
4.	Transplants (Transplant)
5.	Heart Transplantation (Grafting, Heart)
55 Therapies and Procedures and 63 more articles analyzed in the Research Interface, order at left...

Research Interface Subscription

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Searches
2 clicks from Disease to Drug to Evidence
Trial references
All the Positive Outcomes
Drug and Therapy searches
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface Subscription

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>